Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects

Clinical trial NCT07054034 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07054034
Sponsor: Shanghai Mabgeek Biotech.Co.Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bronchial Asthma

Start date: 2025-05-11
Primary completion: 2026-05-26
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.